Brokerages expect that Prestige Consumer Healthcare Inc (NYSE:PBH) will report sales of $232.23 million for the current quarter, according to Zacks. Four analysts have provided estimates for Prestige Consumer Healthcare’s earnings, with the lowest sales estimate coming in at $230.80 million and the highest estimate coming in at $234.70 million. Prestige Consumer Healthcare posted sales of $253.98 million in the same quarter last year, which suggests a negative year-over-year growth rate of 8.6%. The business is expected to report its next earnings report on Thursday, August 1st.
According to Zacks, analysts expect that Prestige Consumer Healthcare will report full-year sales of $954.88 million for the current year, with estimates ranging from $954.00 million to $955.90 million. For the next financial year, analysts forecast that the business will post sales of $964.10 million, with estimates ranging from $963.50 million to $964.60 million. Zacks Investment Research’s sales calculations are an average based on a survey of analysts that that provide coverage for Prestige Consumer Healthcare.
Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings data on Thursday, May 9th. The company reported $0.72 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.70 by $0.02. The company had revenue of $241.03 million for the quarter, compared to analyst estimates of $237.22 million. Prestige Consumer Healthcare had a negative net margin of 3.67% and a positive return on equity of 12.45%. The company’s revenue was down 5.8% on a year-over-year basis. During the same period in the prior year, the firm earned $0.62 earnings per share.
Large investors have recently added to or reduced their stakes in the stock. Arizona State Retirement System boosted its holdings in Prestige Consumer Healthcare by 1.1% in the 4th quarter. Arizona State Retirement System now owns 37,134 shares of the company’s stock valued at $1,147,000 after purchasing an additional 400 shares in the last quarter. Xact Kapitalforvaltning AB boosted its holdings in Prestige Consumer Healthcare by 24.2% in the 4th quarter. Xact Kapitalforvaltning AB now owns 10,781 shares of the company’s stock valued at $333,000 after purchasing an additional 2,100 shares in the last quarter. Rhumbline Advisers boosted its holdings in Prestige Consumer Healthcare by 51.9% in the 4th quarter. Rhumbline Advisers now owns 164,818 shares of the company’s stock valued at $5,090,000 after purchasing an additional 56,282 shares in the last quarter. Chicago Equity Partners LLC purchased a new stake in Prestige Consumer Healthcare in the 4th quarter valued at approximately $999,000. Finally, LSV Asset Management boosted its holdings in Prestige Consumer Healthcare by 183.1% in the 4th quarter. LSV Asset Management now owns 491,784 shares of the company’s stock valued at $15,186,000 after purchasing an additional 318,043 shares in the last quarter.
NYSE:PBH opened at $31.00 on Thursday. Prestige Consumer Healthcare has a 52 week low of $26.25 and a 52 week high of $41.76. The company has a market capitalization of $1.58 billion, a price-to-earnings ratio of 10.94, a price-to-earnings-growth ratio of 1.73 and a beta of 0.89. The business’s 50-day simple moving average is $30.00. The company has a current ratio of 2.37, a quick ratio of 1.43 and a debt-to-equity ratio of 1.64.
About Prestige Consumer Healthcare
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.
Recommended Story: What is a Call Option?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.